$640M Question: 'What Did McKinsey Get' In Big Opioid Deal?
By Jeff Overley · March 31, 2022, 10:43 PM EDT
A California federal judge indicated Thursday that sprawling litigation targeting McKinsey & Co.'s opioid marketing advice will soon see its fate decided by a single thorny question: Were the legal grievances...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login